Cardiac Positron Emission Tomography: a Clinical Perspective

被引：1
作者：
Polte C.L. [1 ,2 ,3 ]
Burck I. [4 ]
Gjertsson P. [5 ]
Lomsky M. [5 ]
Nekolla S.G. [6 ]
Nagel E. [3 ]
机构：
[1] Department of Cardiology, Sahlgrenska University Hospital, Gothenburg
[2] Institute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg
[3] Institute for Experimental and Translational Cardiovascular Imaging, DZHK Centre for Cardiovascular Imaging, University Hospital Frankfurt, Frankfurt/Main
[4] Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt/Main
[5] Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg
[6] Department of Nuclear Medicine, Technical University of Munich, Munich
来源：
Current Cardiovascular Imaging Reports | 2016年 / 9卷 / 3期
关键词：
Cardiovascular inflammation; Myocardial perfusion; Myocardial viability; Patient-centered imaging; Positron emission tomography;
D O I：
10.1007/s12410-016-9371-3
中图分类号：
学科分类号：
摘要：
Cardiac positron emission tomography is a powerful, quantitative, non-invasive imaging modality, which adds valuable diagnostic and prognostic information to the clinical work-up. Myocardial perfusion and viability imaging are, as a result of continuously growing evidence, established clinical indications that may be cost-effective, due to the high diagnostic accuracy of cardiac positron emission tomography, despite high single-test costs. In the field of inflammation imaging, new indications are entering the clinical arena, which may contribute to a better diagnosis and overall patient care, as for instance in patients with cardiac sarcoidosis, prosthetic valve endocarditis and cardiac device infections. This review will discuss the individual strengths and weaknesses of cardiac positron emission tomography and, hence, the resulting clinical usefulness based on the current evidence for an individualized, patient-centered imaging approach. © 2016, Springer Science+Business Media New York.
引用
收藏
页码：1 / 13
页数：12
相关论文
共 129 条
  • [1] Vogel R., Indermuhle A., Reinhardt J., Meier P., Siegrist P.T., Namdar M., Et al., The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation, J Am Coll Cardiol, 45, pp. 754-762, (2005)
  • [2] Baer F.M., Voth E., Deutsch H.J., Schneider C.A., Schicha H., Sechtem U., Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography, J Am Coll Cardiol, 24, pp. 343-353, (1994)
  • [3] Bonow R.O., Dilsizian V., Cuocolo A., Bacharach S.L., Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose, Circulation, 83, pp. 26-37, (1991)
  • [4] Dilsizian V., Arrighi J.A., Diodati J.G., Quyyumi A.A., Alavi K., Bacharach S.L., Et al., Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose, Circulation, 89, pp. 578-587, (1994)
  • [5] Schwitter J., Nanz D., Kneifel S., Bertschinger K., Buchi M., Knusel P.R., Et al., Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography, Circulation, 103, pp. 2230-2235, (2001)
  • [6] Baer F.M., Voth E., Schneider C.A., Theissen P., Schicha H., Sechtem U., Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability, Circulation, 91, pp. 1006-1015, (1995)
  • [7] Klein C., Nekolla S.G., Bengel F.M., Momose M., Sammer A., Haas F., Et al., Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography, Circulation, 105, pp. 162-167, (2002)
  • [8] Knuesel P.R., Nanz D., Wyss C., Buechi M., Kaufmann P.A., von Schulthess G.K., Et al., Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization, Circulation, 108, pp. 1095-1100, (2003)
  • [9] Le Guludec D., Lautamaki R., Knuuti J., Bax J.J., Bengel F.M., Present and future of clinical cardiovascular PET imaging in Europe—a position statement by the European Council of Nuclear Cardiology (ECNC), Eur J Nucl Med Mol Imaging, 35, pp. 1709-1724, (2008)
  • [10] Muzik O., Beanlands R.S., Hutchins G.D., Mangner T.J., Nguyen N., Schwaiger M., Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET, J Nucl Med, 34, pp. 83-91, (1993)
12345678910